From Biopsy to Breakthrough: Real-world Genomics in Early-Stage Oncology Trials

In this episode, ConcertAI CEO Jeff Elton sits down with Mike Rossi, PhD - ConcertAI's Clinical Genomics Lead - to explore how real-world genomic and clinical data are transforming early-stage oncology research. From the evolution of next-generation sequencing to liquid biopsy innovations, they unpack how integrated data sources are helping biopharma optimize study design, reduce trial risk, and accelerate breakthroughs. With insights into AI-powered simulations, patient journey mapping, and the strategic shift toward real-time decision-making, this conversation is essential listening for anyone in translational medicine or clinical development. 

Website
www.ConcertAI.com

LinkedIn
www.linkedin.com/company/concertai/

Twitter
www.twitter.com/concertai